{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:36:05Z","timestamp":1794450965750,"version":"4.9.1"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The advent of proton beam therapy (PBT) has initiated a paradigm shift in the field of pediatric radiation oncology, with increasing promise to alleviate both short-term and long-term toxicities. Given the dramatic rise in proton therapy centers in the United States, a discussion of the quality of evidence supporting its use in pediatric cancers is warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Proton radiotherapy appears to decrease the incidence and severity of late effects with the strongest evidence in pediatric brain tumor cohorts that shows benefits in neurocognitive, hearing, and endocrine outcomes. However, emerging data has shown that more conservative brainstem dose limits with protons compared with photons are required to limit brainstem toxicity; these modified recommendations have been incorporated into national cooperative group studies. Decreased toxicity in tumors outside of the CNS for PBT have also been reported in sarcomas, Hodgkin disease and neuroblastoma. Similarly, QoL outcomes are improved in brain tumor and other cohorts of patients treated with PBT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The collective findings demonstrate improved understanding and refinement of PBT in pediatric cancers. Data on QOL, toxicity and disease outcomes with PBT should continue to be collected and reported in order to understand the full extent of the risks and benefits associated with PBT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000724","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T20:02:44Z","timestamp":1544126564000},"page":"28-34","source":"Crossref","is-referenced-by-count":46,"title":["Proton beam therapy in pediatric oncology"],"prefix":"10.1097","volume":"31","author":[{"given":"Sujith","family":"Baliga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torunn I.","family":"Yock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer Statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1200\/JCO.2018.77.9694","article-title":"Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"36","author":"Hawkins","year":"2018","journal-title":"J Clin Oncol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"key":"R4-20230918","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2014.08.017","article-title":"Quality of life outcomes in proton and photon treated pediatric brain tumor survivors","volume":"113","author":"Yock","year":"2014","journal-title":"Radiother Oncol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1200\/JCO.2011.37.0577","article-title":"Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy","volume":"30","author":"Kuhlthau","year":"2012","journal-title":"J Clin Oncol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2016.09.011","article-title":"Patterns of care in proton radiation therapy for pediatric central nervous system malignancies","volume":"97","author":"Odei","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"(Suppl 5)","key":"R8-20230918","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro Oncol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejpn.2009.12.006","article-title":"Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study","volume":"14","author":"Armstrong","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1200\/JCO.2003.01.202","article-title":"Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study","volume":"21","author":"Packer","year":"2003","journal-title":"J Clin Oncol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jnci\/djt089","article-title":"Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy","volume":"105","author":"Armstrong","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1200\/JCO.2001.19.8.2302","article-title":"Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis","volume":"19","author":"Palmer","year":"2001","journal-title":"J Clin Oncol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1037\/0894-4105.22.2.159","article-title":"Core neurocognitive functions in children treated for posterior fossa tumors","volume":"22","author":"Mabbott","year":"2008","journal-title":"Neuropsychology"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1200\/JCO.2012.46.7050","article-title":"Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies","volume":"31","author":"Schuitema","year":"2013","journal-title":"J Clin Oncol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00381-018-3765-2","article-title":"Medulloblastoma, WNT-activated\/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation","volume":"34","author":"Cambruzzi","year":"2018","journal-title":"Childs Nerv Syst"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1001\/archneur.65.11.1419","article-title":"Management of and prognosis with medulloblastoma: therapy at a crossroads","volume":"65","author":"Packer","year":"2008","journal-title":"Arch Neurol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","article-title":"Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study","volume":"17","author":"Packer","year":"1999","journal-title":"J Clin Oncol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"J Clin Oncol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ddrr.32","article-title":"Neurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual model","volume":"14","author":"Palmer","year":"2008","journal-title":"Dev Disabil Res Rev"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/neuonc\/nor015","article-title":"Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes","volume":"13","author":"Edelstein","year":"2011","journal-title":"Neuro Oncol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-009-9927-z","article-title":"From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000)","volume":"95","author":"Frange","year":"2009","journal-title":"J Neurooncol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","article-title":"Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study","volume":"17","author":"Yock","year":"2016","journal-title":"Lancet Oncol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2015.62.1383","article-title":"Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors","volume":"34","author":"Kahalley","year":"2016","journal-title":"J Clin Oncol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/pbc.24496","article-title":"Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961","volume":"60","author":"Ris","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1200\/JCO.2001.19.15.3470","article-title":"Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study","volume":"19","author":"Ris","year":"2001","journal-title":"J Clin Oncol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1200\/JCO.2013.52.3290","article-title":"Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma","volume":"32","author":"Moxon-Emre","year":"2014","journal-title":"J Clin Oncol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0360-3016(97)00004-7","article-title":"Potential role of proton therapy in the treatment of pediatric medulloblastoma\/primitive neuroectodermal tumors: reduction of the supratentorial target volume","volume":"38","author":"Miralbell","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(03)01574-8","article-title":"Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma","volume":"58","author":"St Clair","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/neuonc\/nos120","article-title":"Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma","volume":"14","author":"Blomstrand","year":"2012","journal-title":"Neuro Oncol"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/neuonc\/not225","article-title":"Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique","volume":"16","author":"Brodin","year":"2014","journal-title":"Neuro Oncol"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ijrobp.2009.09.031","article-title":"Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma","volume":"78","author":"Paulino","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/pbc.24670","article-title":"Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group","volume":"61","author":"Nageswara Rao","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2018.01.002","article-title":"Ototoxicity and cochlear sparing in children with medulloblastoma: proton vs. photon radiotherapy","volume":"128","author":"Paulino","year":"2018","journal-title":"Radiother Oncol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.adro.2017.03.001","article-title":"Effects of vertebral-body- sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastoma","volume":"2","author":"MacEwan","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijrobp.2017.01.226","article-title":"Evaluating intensity modulated proton therapy relative to passive scattering proton therapy for increased vertebral column sparing in craniospinal irradiation in growing pediatric patients","volume":"98","author":"Giantsoudi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/nov302","article-title":"Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma","volume":"18","author":"Eaton","year":"2016","journal-title":"Neuro Oncol"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1227\/NEU.0b013e318214a66e","article-title":"Primary neurosurgery for pediatric low-grade gliomas: a prospective multiinstitutional study from the Children's Oncology Group","volume":"68","author":"Wisoff","year":"2011","journal-title":"Neurosurgery"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MPH.0b013e3182678bf8","article-title":"Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades","volume":"35","author":"Youland","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/j.ijrobp.2011.01.019","article-title":"Outcomes of multidisciplinary management in pediatric low-grade gliomas","volume":"81","author":"Oh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","article-title":"Long- term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low- grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology","volume":"14","author":"Gnekow","year":"2012","journal-title":"Neuro Oncol"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3171\/jns.1995.82.4.0536","article-title":"Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases","volume":"82","author":"Pollack","year":"1995","journal-title":"J Neurosurg"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1200\/JCO.2008.20.9494","article-title":"Phase II trial of conformal radiation therapy for pediatric low-grade glioma","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1200\/JCO.2008.21.2738","article-title":"Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","article-title":"Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors","volume":"36","author":"Vatner","year":"2018","journal-title":"J Clin Oncol"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/COC.0000000000000267","article-title":"Late effects after radiotherapy for childhood low-grade glioma","volume":"41","author":"Williams","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","article-title":"Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma","volume":"192","author":"Harrabi","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2014.04.053","article-title":"Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas","volume":"89","author":"Greenberger","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pbc.26654","article-title":"Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas","volume":"64","author":"Indelicato","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/0284186X.2014.957414","article-title":"Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy","volume":"53","author":"Indelicato","year":"2014","journal-title":"Acta Oncol"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3109\/0284186X.2014.957415","article-title":"Protons, the brainstem, and toxicity: ingredients for an emerging dialectic","volume":"53","author":"Yock","year":"2014","journal-title":"Acta Oncol"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2017.11.026","article-title":"Brainstem injury in pediatric patients with posterior fossa tumors treated with proton beam therapy and associated dosimetric factors","volume":"100","author":"Gentile","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/pbc.26061","article-title":"Late toxicities of intensity-modulated radiation therapy for head and neck rhabdomyosarcoma","volume":"63","author":"Lockney","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I","article-title":"Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group","volume":"33","author":"Raney","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijrobp.2004.02.001","article-title":"Late effects of radiotherapy for pediatric extremity sarcomas","volume":"60","author":"Paulino","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2005.03.052","article-title":"Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons","volume":"63","author":"Yock","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2014.56.1548","article-title":"Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma","volume":"32","author":"Ladra","year":"2014","journal-title":"J Clin Oncol"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2016.05.013","article-title":"Tumour control and quality of life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy","volume":"120","author":"Leiser","year":"2016","journal-title":"Radiother Oncol"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2011.03.038","article-title":"Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes","volume":"82","author":"Rombi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R61-20230918","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26688","article-title":"Pencil beam scanned protons for the treatment of patients with Ewing sarcoma","volume":"64","author":"Weber","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1002\/cncr.26037","article-title":"Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma","volume":"117","author":"Ciernik","year":"2011","journal-title":"Cancer"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/cas.13192","article-title":"Proton beam therapy for bone sarcomas of the skull base and spine: a retrospective nationwide multicentre study in Japan","volume":"108","author":"Demizu","year":"2017","journal-title":"Cancer Sci"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.1984.2.7.719","article-title":"Neuroblastoma: the Joint Center for Radiation Therapy\/Dana-Farber Cancer Institute\/Children's Hospital experience","volume":"2","author":"Rosen","year":"1984","journal-title":"J Clin Oncol"},{"key":"R65-20230918","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1200\/JCO.1991.9.5.789","article-title":"Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma","volume":"9","author":"Castleberry","year":"1991","journal-title":"J Clin Oncol"},{"key":"R66-20230918","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/pbc.24350","article-title":"Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma","volume":"60","author":"Pai Panandiker","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijrobp.2008.10.069","article-title":"Excellent local control from radiation therapy for high-risk neuroblastoma","volume":"74","author":"Gatcombe","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2018.01.008","article-title":"Radiation therapy to sites of metastatic disease as part of consolidation in high-risk neuroblastoma: can long-term control be achieved?","volume":"100","author":"Casey","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R69-20230918","doi-asserted-by":"crossref","DOI":"10.14694\/EdBook_AM.2013.33.e354","article-title":"Photons or protons for noncentral nervous system solid malignancies in children: a historical perspective and important highlights","author":"Daw","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R70-20230918","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1748-717X-8-255","article-title":"Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas","volume":"8","author":"Fuji","year":"2013","journal-title":"Radiat Oncol"},{"key":"R71-20230918","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijrobp.2011.08.035","article-title":"Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison","volume":"83","author":"Hattangadi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R72-20230918","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1748-717X-8-142","article-title":"Clinical results of proton beam therapy for advanced neuroblastoma","volume":"8","author":"Oshiro","year":"2013","journal-title":"Radiat Oncol"},{"key":"R73-20230918","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.1999.17.10.3207","article-title":"Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence","volume":"17","author":"Green","year":"1999","journal-title":"J Clin Oncol"},{"key":"R74-20230918","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/pbc.26044","article-title":"Proton therapy for pediatric Hodgkin lymphoma","volume":"63","author":"Wray","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R75-20230918","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdx287","article-title":"Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma","volume":"28","author":"Hoppe","year":"2017","journal-title":"Ann Oncol"},{"key":"R76-20230918","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2017.04.001","article-title":"Pulmonary toxicity following proton therapy for thoracic lymphoma","volume":"99","author":"Nanda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R77-20230918","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R78-20230918","doi-asserted-by":"crossref","first-page":"323","DOI":"10.14338\/IJPT.13-00006.1","article-title":"The Pediatric Proton Consortium Registry: a Multiinstitutional Collaboration in U.S. Proton Centers","volume":"1","author":"Kasper","year":"2014","journal-title":"Int J Particle Ther"},{"key":"R79-20230918","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fonc.2018.00165","article-title":"An update from the Pediatric Proton Consortium Registry","volume":"8","author":"Hess","year":"2018","journal-title":"Front Oncol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201902000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:19:54Z","timestamp":1694989194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201902000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000724","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}